Fate Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Fate Therapeutics Inc
CIK #0001434316
EDGAR Form CIK 2011 - 2026
10-K [0001434316]
10-Q [0001434316]
3 [0001434316]
4 [0001434316]
8-K [0001434316]
D [0001434316]
SC 13D [0001434316]
SC 13G [0001434316]
Form 13D/13G Filer Form 13D/13G Subject Filed
Schonfeld Strategic Advisors LLC Fate Therapeutics Inc [2025-05-15]
Goldman Sachs Group Inc Fate Therapeutics Inc [2025-05-09]
Boxer Capital LLC Fate Therapeutics Inc [2024-02-12]
Point72 Asset Management LP Fate Therapeutics Inc [2024-01-25]
Millennium Management LLC Fate Therapeutics Inc [2023-03-22]
Capital World Investors Fate Therapeutics Inc [2023-02-13]
State Street Corp Fate Therapeutics Inc [2023-02-03]
Ark Investment Management LLC Fate Therapeutics Inc [2021-09-10]
Vanguard Group Inc Fate Therapeutics Inc [2021-02-10]
Victory Capital Management Inc Fate Therapeutics Inc [2020-01-31]
View All
Form 3/4/5 Subject 2011 - 2026
Fate Therapeutics Inc
Rastetter William H
Epstein Robert S
Agarwal Shefali
Hamill Laura
Abernethy Matt
Lee Michael Stewart
Redmile Group LLC
Green Jeremy
Xu Yuan
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Fate Therapeutics Inc FATE
Common Stock
2026-01-15 Grant 25,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2026-01-15 Grant 75,000 $0.00
Fate Therapeutics Inc FATE
Common Stock
2026-01-15 Grant 100,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2026-01-15 Grant 1,300,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2026-01-15 Grant 400,000 $0.00
Fate Therapeutics Inc FATE
Common Stock
2026-01-15 Grant 335,000 $0.00
Fate Therapeutics Inc FATE
Common Stock
2026-01-09 Sell 5,190 $1.07 5,553
Fate Therapeutics Inc FATE
Common Stock
2026-01-09 Sell 10,589 $1.06 11,224
Fate Therapeutics Inc FATE
Common Stock
2025-10-20 Grant 75,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-10-20 Grant 375,000 $0.00
Fate Therapeutics Inc FATE
Common Stock
2025-08-04 Sell 14,466 $1.06 15,334
Fate Therapeutics Inc FATE
Common Stock
2025-08-04 Sell 9,037 $1.06 9,579
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-05-29 Grant 55,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-05-29 Grant 55,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-05-29 Grant 55,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-05-29 Grant 55,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-05-29 Grant 55,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-05-29 Grant 55,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-05-29 Grant 55,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-05-29 Grant 55,000 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com